| 发明名称 | Targets of <i>Acinetobacter baumannii</i> | ||
| 摘要 | The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides. | ||
| 申请公布号 | US9597387(B2) | 申请公布日期 | 2017.03.21 |
| 申请号 | US201214362058 | 申请日期 | 2012.11.29 |
| 申请人 | Aridis Pharmaceuticals, Inc. | 发明人 | Urwyler Simon;Haake Markus;Rodolf Michael |
| 分类号 | A61K39/104;C07K14/21;C07K16/12;C07K14/22;A61K39/00 | 主分类号 | A61K39/104 |
| 代理机构 | Quine Intellectual Property Law Group P.C. | 代理人 | Quine Intellectual Property Law Group P.C. |
| 主权项 | 1. An antibody that specifically binds to the epitope consensus motif PVDFTVAI shown in SEQ ID NO: 36; wherein said antibody is an IgG capable of inducing an effector function towards Acinetobacter baumannii. | ||
| 地址 | San Jose CA US | ||